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SIJMMARY
In th is study,  the development of  a syslem wi th a constant  rate of  drug
de l i ve r y  acco rd i ng  t o  a  nove l  r e l ease  p r i nc i p l e  i s  desc r i bed .
I n  chap te r  I  t he  r a t i ona le  f o r  con t ro l l ed  r e l ease  p repa ra t i ons  i s
reuíeaed. In chronic medicat ion,  th is type of  dosage form prevai ls  over
t he  conven t i ona l  t ab l e t s  and  capsu les  w i t h  f as t  d rug  re l ease  p rope r t i es :
the regular  f low of  drug f rom the contro l led re lease products may provide
an uni form therapeut ic act ion over an excended per iod of  t i rne,  wi thout .
t he  occu r rence  o f  sub - t he rapeu t i c  o r  t ox i c  peak  1eve l s .  Mo reove r ,  t he rapy
may be improved by the increased paEienE-compl iance,  as a resulË of  the
more convenient  dosage regimen and reduct ion of  the s ide ef fects.
No t  eve ry  d rug  i s  app rop r i a te  t o  be  i nco rpo ïa ted  i n  con t ro l l ed  r e l ease
preparat ions:  less sui table are high dose drugs and drugs wi th a long
ha l f - 1 i f e ,  w i t h  a  l oca l  o r  i r r egu la r  abso rp t i on  i n  t he  gas t ro - i n t es t i na l
t r ac t  o r  w i t h  a  l ack  o f  b l ood  l eve l / ac t i v i t y  r e l a t i onsh ip ,
The gastr ic  residence t ime is a factor  of  major  importance for  the
b ioava i l ab i l i t y  o f  conEro l l ed  re l ease  p roduc t s ,  when  phys io l og i ca l
f ac to r s  o f  t he  d i ges t i ve  sys tem l i ke  pH ,  enz ) rmes ,  b i l e  sa l t s  and  mo t i l i t y
o f  t he  a l imen ta r y  cana l  a f f ec t  t he  ra te  o f  d rug  de l i ve r y .  Fo r  dosage
forms which have the dimensions of  tablets or  capsules,  the t ransi t  rate
through the stomach is dependent on gastr ic  emptying.
In d iscussing the var ious methods to contro l  the re lease of  drug by
ga len i ca l  means ,  o ra l  con t ro l l ed  r e l ease  p roduc t s  ava i l ab l e  i n  Ho l l and
a re  used  as  a  r e fe rence .  The  dosage  f o rms  a re  c l ass i f i ed  as :  l )  en te r i c
coa ted  p repa ra t i ons  2 )  r epea t -ac t i on  p roduc t s  3 )  s l ow  re l ease  pa r t i c l es
i n  capsu les  and  t ab le t s  4 )  mau r i ces  o f  waxes  and  f aÈs  5 )  ma t r i ces  o f
polymers 6)  ion exchange resins and 7)  systems wi th drug re lease by
osmos i s .
Chapter I I  reports on a model  for  the pz, incípLe of  drug re lease f rom a
system, developed in th is study ( the megaLoporous sAsten)
Drug del ivery f rom the system is considered to be the resul t  of  the
interact ion between two phases:  l )  a cont inuous phase (housing phase)
w i t h  s l ow  pene t ra t i on  cha rac te r i s t i c s  f o r  t he  ex t r ac t i on  l i qu i ds  and
2) a phase (r ,estra iníng phase) wi th propert ies of  re leasing drug over
an extended per iod of  ! ime. Iurners ion of  the system causes l iquid
penetrat ion f rom al l  s ides into the housing phase,  compris ing a large
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terA Lax,ge poTes i,n the system (see photograph on page l4l : it shows a
leached skeleton of  the megaloporous system (diarneter  l3 mr) ,  const i tuted
by the insoluble ingredients of  the restra in ing phase).
L iquid penetrat ion into the inner parts of  the device disc loses an
increasing part  of  the restra in ing phase surface a ' rea,  avaí Iable for
drug del ivery to the l iquids in the pores.  Tt .e rate,  at  which the drug
releasing surface of  the restra in ing phase is  exposed to the extract ion
l iquids in the large pores,  deereases wi th respect  to t ime, but
simultaneously, the totaL poz,e suz,face area exposed to the liquids and
contr ibut ing to the re lease process,  increases.  t r íhen the composi t ion of
both phases and the construct ion of  the system are proper ly chosen, th is
process resul ts in a constant  rate of  drug del ivery f rom the device.
Thís modelístic approach of tt'e delivery of drug from the megaloporous
system provides an explanat ion for  the exper imental  resul ts.
Chapter III reports on the effects of eompositíon and consty,uctíon of the
megaloporous system on the ín v i t ro drug del ivery.
Drug re lease f rom the system appears to depend on the concentrat ion of
the insoluble excip ients (carboxyvinyl  polym.er and magnesium stearate)
in the housdng phase, The concentrat ion of  the polymer can be var ied
from 0 ío 157" rd i thout  impeding the character is t ic  of  consËant drug
del ivery f rom the system. For a polymer concentrat ion of  257",  tbe
pa r t i cu l a r  sys tem shows  non - l i nea r  r e l ease  p ro f i l e s .
The concentrat ion of  Eudragi tR RS polymer (at  least  f rom 15 to 302) in
t lne restraíní tq phase,  the in i t ia l  part ic le s ize oÍ  the composi te
granules,  the volume fract ion occupied by the restra in ing phase in the
system, and the concentrat ion of  soluble excip ients in the restra iníng
phase could be changed rni i thout  sacr i f ic ing the phenomenon of  constant
theophyl l ine del ivery f rom the negaloporous system. Only at  h igh loadings
with restra in ing phase mater ia l  (about 757" of  the volugre),  the system
showed a decrease wi th t íme i .n the rate of  drug re lease.
From these exper iments i t  can be concluded, that  the megaloporous system
demonstrates a large f lex ib i l i ty  in preserv ing constant  theophyl l ine
release character is t ics,  when factors of  composi t ion and construct ion are
a l t e red .  Th i s  f l e x i b i l í t y  i s  a  f avou rab le  p rope r t y ,  as  i t  i nd i ca tes  t ha t '
drugs wi th d i f ferent  water-solubi l i t ies may be incorporated succesful ly
wi th respect  to the constaÍr t  re lease character is t ics of  the system.
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r n  chap te r  ï v '  t he  r e l ease  cha rac te r i s t i c s  o f  t heophy l l i ne  f r om rwo
formulat ions of  the megaloporous syslem (preparat ions B and c)  and f rom
P
Theol in^ '  retard (preparat ioo L)  in u i tz ,o as wel l  as ín u i . t to are
eva lua ted .  P repa ra t i on  A  was  i nc l uded  as  a  r e fe rence ,  s i nce  i t  has
demonstrated adequate contro l led re lease propert ies in v ivo,  approaching
the ideal  of  constant  drug del ivery in v ivo more c losely than oEher
commerc ia l l y  ava i l ab l e  t heophy l l i ne  p roduc t s  (Hende les  e t  a l .  ( 19g4 ) ) .
I n  o i t t o ,  p repa ra t i on  A  demons t ra tes  a  b i phas i c  d rug  re l ease  p ro f i l e ,
wh i ch  appea rs  t o  be  sens i t i ve  t o  t he  pH  and  t he  d i sso lu t i on  mode1 .  The
ex t rac t i on  ra tes  o f  t heophy l l i ne  i n  ac i d i c  cond i t i ons  i s  cons tan t ,
s imi lar  and independent of  the dissolut ion model  for  both megaloporous
sys tems .  I n  bu f f e red  med ium (pH  6 .8 ) ,  t he  raEe  o f  d rug  de l i ve r y  f r om
megaloporous preparat ion B is  found to be lower in the paddle apparatus
and  f o r  mega lopo rous  p repa ra t i on  c  f as te r  i n  t he  mod i f i ed  d i s i n teg ra t i on
tes te r ,  when  compared  t o  t he  ra tes  i n  t he  respec t i ve  d i sso lu t i on  mode l s
a t  p H  l .
The three dosage forms were evaluated ín r t iuo,  wi th a neutra l  solut ion
o f  t heophy l l i ne  as  a  r e fe rence .  P repa ra t i on  B  re l eased  i t s  t heophy l l i ne
content  incompletely dur ing the 32 h of  p lasma measuremeÍr ts,  whereas no
s ign i f i can t  d i f f e rence  f r om comp le te  abso rp t i on  was  f ound  f o r  e i t he r
p repa ra t i on  A  o r  p repa ra t i on  C .
To  a l l ow  compar i son  o f  t he  i n  v i vo  r e l ease  f r om o ra l  con t ro l l ed  r e l ease
dosage forms wi th t lne ídeal  pez, fotrnance ( Ip)  in v ivo,  a value ( the DIp)
is int roduced, which represents the quant iËat ive deviat ion between lhe
release f rom the dosage form and the ideal  performance in v ivo.
Preparat ion A shows a s imi lar  DlP-value as megaloporous preparaEion C.
The DIP-value for  preparat ion B is  found to be considerably h igher,
i nd i ca t i ng  t ha t  t he  re l ease  f r om th i s  p repa ra t i on  i n  v i vo  d .ev i a tes  mo re
f rom l i nea r i t y .
The in v ivo del ivery of  theophyl l ine f rom preparat ion A and preparat ion
C compared \ , r i th the re lease of  the drug f rom both preparat ions in v i t ro
revea l s ,  t ha t  t he  ra te  i n  t he  two  d i sso lu t i on  mode l s  appea rs  t o  be  abou t
1 .5  t imes  f as te r  t han  t he  raÈe  f o r  t he  p repa ra t i ons  i n  v i vo .
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a system, which di f fers f rom the megaloporous system wi th respeet to
conposi t ion and construct ion.  The same model  for  the drug del ivery
pr incip le is  appl ied,  as appeared useful  for  the megaloporous system
(  Chap te r  I I ) .  The  re l ease  o f  d i sso l ved  d rug  f r om these  ca r r i e r s  o f
drug contain ing part ic les is  calculated by mathemat ical ly  solv ing a
convolut ion integral .
In general  i t  can be concluded that  the re lease character is t ics of
spher ical  carr iers compris ing t ts low-releaset '  drug part ic les deviate
less f rom l inear i ty  than the re lease prof i le of  a spher ical  drug
pa r t i c l e .
I {hen a second monodisperse system of  isometr ic  drug part ic les is
incorporated ín one carr ier ,  the re lease k inet ics deviate even less f rom
l inear i ty .
An approximate\y constant rate of drug release is shown by a system of
hio carríers, each containing one motodísperse system of drug particles.
tríhen the parameters affecting drug delivery from this system are
proper ly chosen, the in i t ia l  deviat ion f rom l inear i ty  in the amount of
drug re leased f rom one of  the carr iers is  completely e l iminated by the
release of  drug f rom the second carr ier .  This system of  two carr iers
del ivers about 802 of  i ts  drug content  at  a constant  rate.
This theoret ical  s tudy shows, that  the appl icat ion of  a system of  two
carr iers,  coÍrpr is ing "s low-releaserr  drug part ic les and re l -easing the drug
by a process of  surface erosion or  d issolut ion,  appears to be an
interest ing tool  in the development of  systems wi th constant  drug del ivery
cha rac te r i s t i c s .
I l ende les ,  L . ,  I a f r a te ,  R .P . ,  and  t r / e i nbe rge r ,  M . ,  A  c l i n i ca l  and
pharmacokinet ic  basis for  the selecËion and use of  s1o\ , r  re lease
theophy l l i ne  p roduc t s .  C l i n í ca l  Pha rmacok ine t i c s ,  9 (1984 )  95 -135 .
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